"The SCAAR data represent 'real-world' outcomes that show how Swedish doctors' technique improved over time because of more experience implanting drug-eluting stents resulting in improved outcomes for patients," says SCAI Secretary Steven R. Bailey, M.D., FSCAI, Interim Chief of the Division of Cardiology, Professor of Medicine and Radiology, and Janey Briscoe Distinguished Chair at the University of Texas Health Sciences Center at San Antonio. "Our patients can be reassured by these findings. If their interventional cardiologist chooses to implant a drug-eluting stent, they are receiving a safe and effective treatment."
To explain the new findings, Dr. Weiner points to indications that physicians' technique with the stents has improved and stent patients are now more likely to be on strict regimens of anti-clotting medications for a longer period. SCAI reemphasizes the need for high-quality education and training that will guide physicians in evaluating the benefits and risks of DES for each patient, depending on his or her age, gender, co-morbid conditions, and complexity of disease.
In addition, both physicians and patients need further education on the
importance of a strict regimen of both clopidogrel and aspirin, two drugs
that help prevent the formation of blood clots. SCAI, a leader in physician
education, urges doctors to review the Clinical Alert the Society issued in
early 2007
(http://www.scai.org/pdf/DES%20clinical%20alert%20in%20CCI%20Feb07.pdf),
which stresses that physicians must take care to use DES in the right
patients and the right blood vessels, an
'/>"/>
| SOURCE Society for Cardiovascular Angiography and Interventions Copyright©2007 PR Newswire. All rights reserved |